Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeW. L. Gore & Associates Inc.Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium®

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium®

To be Presented at the 45th Annual VEITHsymposium®

W. L. Gore & Associates, Inc. (Gore) will highlight data gleaned from its Global Registry for Endovascular Aortic Treatment (GREAT) Study at the 45th Annual Symposium on Vascular and Endovascular Issues, VEITHsymposium® in New York. The company is featuring the data in multiple presentations facilitated by lead investigators. GREAT is the largest industry-sponsored registry of aortic stent grafts with enrollment and follow-up data from over 100 sites across 13 countries.

“We launched this registry in 2010 to evaluate and better understand how our family of aortic devices perform in real-world applications, and as a reflection of our continued commitment to advancing patient care in the treatment of aortic disease,” said Eric Zacharias, Vascular Business Leader. “The GREAT study draws from a pool of 5,000 patients who received one or more of the GORE® EXCLUDER® AAA Endoprostheses, GORE® EXCLUDER® Iliac Branch Endoprostheses, or Conformable GORE® TAG® Thoracic Endoprostheses. We are excited to share some of the conclusions and better inform our product offerings.”

GREAT had broad inclusion criteria with minimal exclusion criteria to more accurately reflect real world clinical practice. Treatment results will be tracked for 10 years. This follow-up has and will continue to provide valuable insights into the long-term durability and behavior of Gore aortic endografts.

“Traditionally, the industry has captured and shared data on migration, endoleak rates, rupture, conversions, and a few other data points,” said Ross Milner, Professor of Surgery and Co-Director of the Center for Aortic Diseases at the University of Chicago Medical Center and National Co-Principal Investigator for GREAT in the US. In contrast, the GREAT investigators have been able to query the data to get insights into previously unanswered, rarely asked, or often unexplored areas of treatment. Our lunch symposium will explore a few of those topics.”

Panel discussions on GREAT and the resulting observations will take place in the Main Pavilion, Mercury Ballroom, starting 12 p.m. EST Friday, November 16. The discussion will include the comprehensive portfolio of aortic products.

  • Friday, Nov. 16: GREAT aortic endografting questions: What does the data reveal?

Pierre Galvagni Silveira, MD, Florianopolis, Brazil
Andrew Holden, MD, Auckland, New Zealand
Santi Trimarchi, MD, Milan, Italy

  • The GREAT update: A review of one of the largest clinical registries for abdominal and thoracic aortic devices
    Beth Tohill, PhD, Flagstaff, Arizona
  • Acute and chronic Type B aortic dissections: Exploring the nuances behind the data
    Dennis Gable, MD, Dallas, Texas
  • Noncylindrical neck morphology: Incidence, effects, and risk of reintervention
    William Shutze, MD, Dallas, Texas
  • Performance in the narrow distal aorta: Findings and implications
    Ross Milner, MD, Chicago

In addition to GREAT Registry discussions, Gore Medical will be hosting daily educational events at VEITHsymposium 2018, see full agenda here.

For more information on Gore aortic portfolio of products, visit

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy